Trial intelligence / Profile preview

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells in Recurrent Glioblastoma Multiforme

NCT04002804Phase 1Terminated

Sponsor: Carlo Besta Neurological Institute
Start: Apr 2010
Primary completion: Oct 2011

Overview

Phase 1, open-label, single-arm trial in glioblastoma multiforme (GBM), sponsored by Carlo Besta Neurological Institute. Primary endpoint: Percentage of Participants With Progression Free Survival at 6 Months. Started Apr 2010; status: terminated.

Conditions

glioblastoma multiforme (GBM)

Beyond the preview

Go deeper on NCT04002804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04002804.